clinical trial · NCT00237263
An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States
Novartis·phase2·completed·n = 285
Parkinson's DiseaseEntacapone
brief summary
The purpose of this study is to evaluate the safety and efficacy of the long-term treatment of entacapone in patients with Parkinson's disease with end-of-dose wearing-off. This study is not recruiting patients in the United States.
started
Feb 1, 2003
primary completion
Jul 1, 2007
completion
Jul 1, 2007
last updated
Jan 11, 2024
detailed description
The purpose of this study is to evaluate the safety and efficacy of the long-term treatment of entacapone in patients with Parkinson's disease with end-of-dose wearing-off.
official title
An Extension Study to Phase IIb Dose-finding Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol